At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke

Prompting patients to keep tabs on their blood pressure at home can reduce their risk of heart attack, stroke and heart disease, a new study says.

People were 34% less likely to be hospitalized or die from heart attack, stroke or heart failure if they self-monitored their blood pressure at home and shared the readings with their doctors.

Family Finances Shape Children’s Brain Development, Study Finds

A family’s financial situation has more impact on their children’s brain development than parenting style, a new study says.

Family finances and opportunities in a child’s neighborhood account for about 16% of the variability in kids’ brain function — far more than IQ, health history or how their parents raise...

People Walk, Exercise Less After Starting Ozempic, Zepbound

Folks losing weight on Ozempic or Zepbound tend to start slacking off when it comes to exercise, a new study says.

People’s daily step count and physical activity declined after starting a GLP-1 medication, researchers reported Saturday at the Endocrine Society’s annual meeting in Chicago.

“While many assume that we...

Many Men Are Prescribed Testosterone Without Proper Testing

Men prescribed testosterone might not be getting important and required testing beforehand, a new study says.

A little over 1 in 10 men (12%) received testing that would accurately diagnose them with low testosterone levels prior to being prescribed the hormone, researchers reported Saturday at the Endocrine Society’s annual meeting ...

Organic Baby Formula Recalled Following Botulism Cases

The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of infant botulism linked to Nara Organics Whole Milk Organic Powdered Infant Formula.

Three infants in California, Pennsylvania and Washington have been diagnosed with toxin type A infections after consuming formula in April or May.

Nara Organics Powd...

FDA Approves First Over-the-Counter Glucose Monitor for Children

The U.S. Food and Drug Administration (FDA) has cleared the first over-the-counter wearable device to track blood sugar in young children.

The continuous glucose monitor (CGM) — called the Stelo Glucose Biosensor System — is for use in children as young as 2 years old who do not use insulin.

This marks the first time a CG...